Published in Adv Immunol on January 01, 1976
Suppression of in vivo polyclonal IgE responses by monoclonal antibody to the lymphokine B-cell stimulatory factor 1. Proc Natl Acad Sci U S A (1986) 4.69
T cell-derived B cell differentiation factor(s). Effect on the isotype switch of murine B cells. J Exp Med (1982) 4.51
Biological activities of crystalline pertussigen from Bordetella pertussis. Infect Immun (1981) 3.16
T-cell regulation of murine IgA synthesis. J Exp Med (1979) 3.11
Inhibition of specific IgE responses in mice by pre-exposure to inhaled antigen. Immunology (1981) 2.01
Subpopulations of circulating B cells and regulatory T cells involved in in vitro immunoglobulin E production in atopic patients with elevted serum immunoglobulin E. J Clin Invest (1980) 1.68
Clonal and molecular characteristics of the human IgE-committed B cell subset. J Exp Med (1989) 1.50
Recent studies on the regulation of IgE antibody synthesis in experimental animals and man. Immunology (1980) 1.28
In vitro selective expansion of allergen specific T cells from atopic patients. Clin Exp Immunol (1983) 1.21
In vitro stimulation of IgE production at a single precursor level by human alloreactive T helper clones. Clin Exp Immunol (1984) 1.11
In vitro synthesis of IgE by human peripheral blood leucocytes. II modulation of IgE B cell activity by isotype-specific regulatory T cells. Clin Exp Immunol (1981) 1.07
Nonspecific suppression of primary antibody responses and presence of plastic-adherent suppressor cells in Toxoplasma gondii-infected mice. Infect Immun (1981) 1.05
Stimulation of primary in vitro IgE antibody responses in culture of human peripheral mononuclear cells. J Exp Med (1981) 1.02
IgE class-restricted tolerance induced by neonatal administration of soluble or cell-bound IgE. J Exp Med (1983) 0.97
Regulation of immunoglobulin E antibody synthesis in man by antiidiotypic antibodies. J Clin Invest (1983) 0.86
Eosinophil involvement in rheumatoid arthritis as reflected by elevated serum levels of eosinophil cationic protein. Clin Exp Immunol (1985) 0.85
IgE class-restricted tolerance induced by neonatal administration of soluble or cell-bound IgE. Cellular mechanisms. J Exp Med (1984) 0.84
Immunological properties of conjugates of ragweed pollen antigen E with methoxypolyethylene glycol or a copolymer of D-glutamic acid and D-lysine. J Exp Med (1979) 0.83
Specific and total IgE responses to antigenic stimuli in Brown-Norway, Lewis and Sprague-Dawley rats. Immunology (1980) 0.83
IgE production in vitro by peripheral blood mononuclear cells of patients with parasitic helminth infections. Clin Exp Immunol (1984) 0.82
Antigenic competition in IgE antibody production. I. Establishment of parameters involved in primary and secondary responses. Immunology (1980) 0.82
Nonspecific suppression of initiation of memory cells in Toxoplasma gondii-infected mice. Infect Immun (1981) 0.81
Regulation of immunoglobulin E production in mice immunized with an extract of Toxoplasma gondii. Infect Immun (1989) 0.80
Receptor-specific mediation by immunoglobulin E of antigen-induced contraction of tracheal and lung parenchymal strips isolated from the guinea pig. J Clin Invest (1984) 0.78
Special regulatory T-cell review: T-cell dependent suppression revisited. Immunology (2008) 0.77
Increase in peripheral blood 'null' cells in extrinsic bronchial asthma. Clin Exp Immunol (1977) 0.75
Hyposensitization therapy. Can Fam Physician (1987) 0.75
Inhibition of an IgE response by secondary B cells of a different isotype. J Exp Med (1986) 0.75
Humoral and cellular immune response of the rat to immunization with bee venom. Clin Exp Immunol (1984) 0.75
Immunopathology. Am J Pathol (1978) 0.75
Patient education in asthmatic children. Lung (1990) 0.75
Activation of the alternate pathway of human complements by rabbit cells. J Immunol (1974) 5.59
Magnetic control of ferroelectric polarization. Nature (2003) 5.23
Biologic activities of aggregated gamma-globulin. 8. Aggregated immunoglobulins of different classes. J Immunol (1967) 3.37
Identification of gamma-E-antibodies as a carrier of reaginic activity. J Immunol (1967) 3.05
Physicochemical properties of reaginic antibody. V. Correlation of reaginic activity wth gamma-E-globulin antibody. J Immunol (1966) 2.92
Mechanisms of passive sensitization. I. Presence of IgE and IgG molecules on human leukocytes. J Immunol (1970) 2.91
Distribution of gamma E-forming cells in lymphoid tissues of the human and monkey. J Immunol (1970) 2.66
Physico-chemical properties of human reaginic antibody. IV. Presence of a unique immunoglobulin as a carrier of reaginic activity. J Immunol (1966) 2.62
Regulation of IgE synthesis. Annu Rev Immunol (1984) 2.61
Stimulation of phospholipid methylation, Ca2+ influx, and histamine release by bridging of IgE receptors on rat mast cells. Proc Natl Acad Sci U S A (1980) 2.50
Regulation of antibody response in vitro. VI. Carrier-specific helper cells for IgG and IgE antibody response. J Immunol (1973) 2.33
Biologic function of the Fc fragments of E myeloma protein. Immunochemistry (1970) 2.23
Selective differentiation and proliferation of hematopoietic cells induced by recombinant human interleukins. Proc Natl Acad Sci U S A (1988) 2.22
Lymphocytes bearing Fc receptors for IgE. I. Presence of human and rat T lymphocytes with Fc epsilon receptors. J Immunol (1979) 2.20
Generation of specific helper cells and suppressor cells in vitro for the IgE and IgG antibody responses. J Immunol (1976) 2.18
Biology of immunoglobulin E. Molecular basis of reaginic hypersensitivity. Prog Allergy (1975) 2.15
A research standard for human serum immunoglobulin E. Bull World Health Organ (1970) 2.05
Activation of mast cells for mediator release through IgE receptors. Prog Allergy (1984) 2.01
Genetic control of basal serum immunoglobulin E level and its effect on specific reaginic sensitivity. Proc Natl Acad Sci U S A (1974) 1.98
Proteolytic degradation of exocrine and serum immunoglobulins. J Clin Invest (1970) 1.97
IgA and IgA diphtheria antitoxin responses from human tonsil lymphocytes. J Immunol (1975) 1.97
Mechanisms of passive sensitization. 3. Number of IgE molecules and their receptor sites on human basophil granulocytes. J Immunol (1973) 1.87
Clinical aspects of IgE myeloma. N Engl J Med (1969) 1.85
Histamine release from human leukocytes by anti-gamma E antibodies. J Immunol (1969) 1.84
Triggering of histamine release from rat mast cells by divalent antibodies against IgE-receptors. J Immunol (1978) 1.84
Immunologic and cellular changes accompanying the therapy of pollen allergy. J Clin Invest (1971) 1.80
C'-1 fixation by human isoagglutinins: fixation of C'-1 by gamma-G and gamma-M but not by gamma-A antibody. J Immunol (1966) 1.80
Reversed type allergic skin reactions by anti-gamma-E-globulin antibodies in humans and monkeys. J Immunol (1968) 1.75
Development of rat mast cells in vitro. I. Differentiation of mast cells from thymus cells. J Immunol (1976) 1.74
Immunochemical properties of human gamma-A isohemagglutinin. I. Comparisons with gamma-G and gamma-M-globulin antibodies. J Immunol (1965) 1.72
Mechanisms of passive sensitization. IV. Dissociation of IgE molecules from basophil receptors at acid pH. J Immunol (1974) 1.62
Immune mechanisms of reversed type reaginic hypersensitivity. J Immunol (1969) 1.61
IgE antibody measurements in ragweed hay fever. Relationship to clinical severity and the results of immunotherapy. J Clin Invest (1973) 1.58
Direct demonstration of increased intracellular concentration of free calcium as measured by quin-2 in stimulated rat peritoneal mast cell. Proc Natl Acad Sci U S A (1984) 1.58
Presence of gammaE in nasal washings and sputum from asthmatic patients. J Allergy (1970) 1.56
Biological function of gamma E antibodies and mechanisms of reaginic hypersensitivity. Clin Exp Immunol (1970) 1.56
Human reaginic antibodies and immunoglobulin E. J Allergy (1968) 1.55
Formation of IgE binding factors by human T lymphocytes. J Immunol (1981) 1.53
Mechanisms of reaginic hypersensitivity and IgE antibody response. Immunol Rev (1978) 1.52
Identification of basophil granulocytes as a site of allergic histamine release. J Immunol (1972) 1.52
Immunoglobulin switch circular DNA in the mouse infected with Nippostrongylus brasiliensis: evidence for successive class switching from mu to epsilon via gamma 1. Proc Natl Acad Sci U S A (1990) 1.49
Development of mast cells in vitro. II. Biologic function of cultured mast cells. J Immunol (1977) 1.48
Surface IgE on human basophils during histamine release. J Exp Med (1973) 1.48
The capacity of human immunoglobulin E to mediate the release of histamine and slow reacting substance of anaphylaxis (SRS-A) from monkey lung. J Immunol (1970) 1.48
Induction of calcium flux across the rat mast cell membrane by bridging IgE receptors. Proc Natl Acad Sci U S A (1979) 1.47
An essential role of mast cells in the development of airway hyperresponsiveness in a murine asthma model. J Immunol (2000) 1.47
Biochemical analysis of initial triggering events of IgE-mediated histamine release from human lung mast cells. J Immunol (1983) 1.47
Suspension culture of human mast cells/basophils from umbilical cord blood mononuclear cells. Proc Natl Acad Sci U S A (1983) 1.44
Lymphocytes bearing Fc receptors for IgE. II. Induction of Fcepsilon-receptor bearing rat lymphocytes by IgE. J Immunol (1979) 1.43
Immunoglobulin E deficiency in ataxia-telangiectasia. N Engl J Med (1969) 1.42
Sex differences in function and distribution of beta-adrenoceptors in rabbit urinary bladder. J Urol (1998) 1.42
cDNA clones encoding IgE-binding factors from a rat-mouse T-cell hybridoma. Proc Natl Acad Sci U S A (1985) 1.41
Regulation of antibody response in vitro. VII. Enhancing soluble factors for IgG and IgE antibody response. J Immunol (1973) 1.41
Regulatory role of IgE-binding factors from rat T lymphocytes. II. Glycoprotein nature and source of IgE-potentiating factor. J Immunol (1980) 1.40
Immunogenic properties of modified antigen E. II. Ability of urea-denatured antigen and alpha-polypeptide chain to prime T cells specific for antigen E. J Immunol (1975) 1.40
Induction of Fc epsilon-receptor bearing cells in vitro in human peripheral lymphocytes. J Immunol (1980) 1.39
Physiochemical properties of reaginic antibody. II. Characteristic properties of reaginic antibody different from human gamma-A-isohemagglutinin and gamma-D-globulin. J Allergy (1966) 1.39
Human IgG and IgA diphtheria antitoxins in serum, nasal fluids and saliva. J Immunol (1969) 1.37
IgE formation in the rat following infection with Nippostrongylus brasiliensis. I. Proliferation and differentiation of IgE-bearing cells. Cell Immunol (1976) 1.37
Release of histamine and slow reacting substance of anaphylaxis (SRS-A) by IgE-anti-IgE reactions on monkey mast cells. J Immunol (1972) 1.37
Regulatory role of IgE-binding factors from rat T lymphocytes. III. IgE-specific suppressive factor with IgE-binding activity. J Immunol (1980) 1.36
Induction of erythema-wheal reactions by soluble antigen-gammaE antibody complexes in humans. J Immunol (1968) 1.36
Mechanisms of reaginic hypersensitivity: a review. Clin Allergy (1971) 1.35
The significance of immunoglobulin E in reaginic hypersensitivity. Ann Allergy (1970) 1.34
Regulatory role of IgE-binding factors from rat T lymphocytes. I. Mechanism of enhancement of IgE response by IgE-potentiating factor. J Immunol (1980) 1.33
Pharmacologic inhibition of the antigen-induced release of histamine and slow reacting substance of anaphylaxis (SRS-A) from monkey lung tissues mediated by human IgE. J Immunol (1971) 1.32
Lymphocytes bearing Fc receptors for IgE. IV. Formation of IgE-binding factor by rat T lymphocytes. J Immunol (1980) 1.32
Formation of IgE-binding factors by human T-cell hybridomas. Proc Natl Acad Sci U S A (1984) 1.32
Inhibition of phosphatidylinositol 3-kinase activity by association with 14-3-3 proteins in T cells. Proc Natl Acad Sci U S A (1995) 1.31
Physicochemical properties of reaginic antibody. VI. Effect of heat on gamma-E-, gamma-G- and gamma-A-antibodies in the sera of ragweed sensitive patients. J Immunol (1967) 1.31
Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. Proc Natl Acad Sci U S A (1993) 1.30
The low-affinity receptor for IgE (CD23) on B lymphocytes is spatially associated with HLA-DR antigens. J Exp Med (1988) 1.29
Reaginic antibody formation in the mouse. VI. Suppression of IgE and IgG antibody responses to ovalbumin following the administration of high dose urea-denatured antigen. Cell Immunol (1975) 1.27
Reaginic antibody formation in the mouse. XI. Participation of long-lived antibody-forming cells in persistent antibody formation. Cell Immunol (1981) 1.27
Tyrosine phosphorylation is required for mast cell activation by Fc epsilon RI cross-linking. J Immunol (1992) 1.27
Regulation of antibody response in vitro. IX. Induction of secondary anti-hapten IgG antibody response by anti-immunoglobulin and enhancing soluble factor. J Immunol (1975) 1.27
A simplified procedure for the preparation of immunoglobulin-class-specific antisera. J Immunol (1969) 1.26
In vitro reversed anaphylaxis: characteristics of anti-IgE mediated histamine release. Immunology (1970) 1.24
Histamine release from rat mast cells by antibodies against rat basophilic leukemia cell membrane. J Immunol (1977) 1.24
Physicochemical properties of reaginic antibody. 1. Association of reaginic activity with an immunoglobulin other than gammaA- or gammaG-globulin. J Allergy (1966) 1.23
IgE and reaginic hypersensitivity. Ann N Y Acad Sci (1971) 1.23
Presence of an antigenic determinant common to rat IgE-potentiating factor, IgE-suppressive factor, and Fc epsilon receptors on T and B lymphocytes. J Immunol (1984) 1.22
Measurement of IgE antibody by an antigen-binding assay: correlation with PK activity and IgG and IgA antibodies to allergens. J Immunol (1978) 1.22
Requirement of Notch 1 and its ligand jagged 2 expressions for spermatogenesis in rat and human testes. J Androl (2001) 1.22
Diagnostic tests in ragweed hay fever. A comparison of direct skin tests, IgE antibody measurements, and basophil histamine release. J Allergy Clin Immunol (1973) 1.20
Reaginic antibody formation in the mouse. VII. Induction of suppressor T cells for IgE and IgG antibody responses. J Immunol (1976) 1.20
Immunoglobulin E: a new class of human immunoglobulin. Immunology (1968) 1.19
Molecular cloning and functional expression of a cDNA encoding glycosylation-inhibiting factor. Proc Natl Acad Sci U S A (1993) 1.19
Human diphtheria antitoxin in immunoglobulin classes IgG and IgA. J Immunol (1967) 1.18
Immunogenic properties of modified antigen E. I. Presence of specific determinants for T cells in denatured antigen and polypeptide chains. J Immunol (1974) 1.17
IgE in atopic dermatitis. Arch Dermatol (1971) 1.17
IgA and IgG anti-ragweed antibodies in nasal secretions. Quantitative measurements of antibodies and correlation with inhibition of histamine release. J Clin Invest (1976) 1.17
Antigenic structure of gamma-E-globulin and reaginic antibody. J Immunol (1967) 1.15
IgE levels in sera of children with asthma. Pediatrics (1971) 1.15
Lymphocytes bearing receptors for IgE. III. Transition of Fc gamma R(+) cells to Fc epsilon R(4) cells by IgE. J Immunol (1979) 1.14
Bridging of IgE receptors activates phospholipid methylation and adenylate cyclase in mast cell plasma membranes. Proc Natl Acad Sci U S A (1981) 1.14
Regulatory role of IgE-binding factors from rat T lymphocytes. V. The carbohydrate moieties in IgE-potentiating factors and IgE-suppressive factors. J Immunol (1982) 1.14
Degranulation of human basophil leukocytes by anti-gamma E antibody. J Immunol (1971) 1.14
Fixation of C' and C'la by rabbit gamma-G- and gamma-M-antibodies with particulate and soluble antigens. J Immunol (1968) 1.14
Antigen-induced increase in protein kinase C activity in plasma membrane of mast cells. Proc Natl Acad Sci U S A (1985) 1.13